The DOI matches its Crossref record; 25 of the 27 references it cites were found in a registry or an index.
Silencing of microRNAs in vivo with ‘antagomirs’
Abstract
MicroRNAs (miRNAs) are an abundant class of non-coding RNAs that are believed to be important in many biological processes through regulation of gene expression. The precise molecular function of miRNAs in mammals is largely unknown and a better understanding will require loss-of-function studies in vivo. Here we show that a novel class of chemically engineered oligonucleotides, termed 'antagomirs', are efficient and specific silencers of endogenous miRNAs in mice. Intravenous administration of antagomirs against miR-16, miR-122, miR-192 and miR-194 resulted in a marked reduction of corresponding miRNA levels in liver, lung, kidney, heart, intestine, fat, skin, bone marrow, muscle, ovaries and adrenals. The silencing of endogenous miRNAs by this novel method is specific, efficient and long-lasting. The biological significance of silencing miRNAs with the use of antagomirs was studied for miR-122, an abundant liver-specific miRNA. Gene expression and bioinformatic analysis of messenger RNA from antagomir-treated animals revealed that the 3' untranslated regions of upregulated genes are strongly enriched in miR-122 recognition motifs, whereas downregulated genes are depleted in these motifs. Analysis of the functional annotation of downregulated genes specifically predicted that cholesterol biosynthesis genes would be affected by miR-122, and plasma cholesterol measurements showed reduced levels in antagomir-122-treated mice. Our findings show that antagomirs are powerful tools to silence specific miRNAs in vivo and may represent a therapeutic strategy for silencing miRNAs in disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Methods have been developed to manipulate miRNA function pharmacologically, facilitating the development of new cancer therapeutic strategies (Hutvagner et al., 2004; Krutzfeldt et al., 2005).”
From Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21 (2010) · cites this paper as Krutzfeldt et al., 2005
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
The functions of animal microRNAs
Ambros, V. (2004) · Nature · doi:10.1038/nature02871 · Cited by 10,728
MicroRNA expression profiles classify human cancers
Lü, J., Getz, G. A., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,637
MicroRNAs: small RNAs with a big role in gene regulation
He, L., & Hannon, G. J. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1379 · Cited by 7,118
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs
Lim, L. P., Lau, N. C., Garrett-Engele, P., Grimson, A., Schelter, J. M., Castle, J., Bartel, D. P., Linsley, P. S., & Johnson, J. M. (2005) · Nature · doi:10.1038/nature03315 · Cited by 4,755
Combinatorial microRNA target predictions
Krek, A., Grün, D., Poy, M. N., Wolf, R., Rosenberg, L., Epstein, E. J., MacMenamin, P., da Piedade, I., Gunsalus, K. C., Stoffel, M., et al. (2005) · Nature Genetics · doi:10.1038/ng1536 · Cited by 4,603
Self-citationPruitt, K. D., Tatusova, T. A., & Maglott, D. R. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl842 · Cited by 4,441
John, B., Enright, A. J., Aravin, A., Tuschl, T., Sander, C., & Marks, D. S. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020363 · Cited by 3,796
Self-citationA microRNA polycistron as a potential human oncogene
He, L., Thomson, J. M., Hemann, M. T., Hernando, E., Mu, D., Goodson, S. G., Powers, S., Cordon‐Cardo, C., Lowe, S. W., Hannon, G. J., et al. (2005) · Nature · doi:10.1038/nature03552 · Cited by 3,642
Cited by
Sorted by citations
Items 301–400 of 1,017
Apoptosis and Necrosis in the Liver
Guicciardi, M. E., Malhi, H., Mott, J. L., & Gores, G. J. (2013) · Comprehensive physiology · doi:10.1002/cphy.c120020 · Cited by 403
MicroRNAs in colorectal cancer: translation of molecular biology into clinical application
Slabý, O., Svoboda, M., Michálek, J., & Vyzula, R. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-102 · Cited by 361
miRNA-223 Promotes Gastric Cancer Invasion and Metastasis by Targeting Tumor Suppressor EPB41L3
Li, X., Zhang, Y., Zhang, H., Liu, X., Gong, T., Li, M., Sun, L., Ji, G., Shi, Y., Han, Z., et al. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0529 · Cited by 356
MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths
Sayed, D., Rane, S., Lypowy, J., He, M., Chen, I.-Y., Vashistha, H., Yan, L., Malhotra, A., Vatner, D., & Abdellatif, M. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-02-0159 · Cited by 355
Non-coding RNA in hepatocellular carcinoma: Mechanisms, biomarkers and therapeutic targets
Klingenberg, M., Matsuda, A., Diederichs, S., & Patel, T. C. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.04.009 · Cited by 355
Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells
Venturini, L., Battmer, K., Castoldi, M., Schultheis, B. S., Hochhaus, A., Muckenthaler, M. U., Ganser, A., Eder, M., & Scherr, M. (2007) · Blood · doi:10.1182/blood-2006-09-045104 · Cited by 357
Moschos, S. A., Jones, S. W., Perry, M. M., Williams, A. E., Erjefalt, J. S., Turner, J. J., Barnes, P. J., Sproat, B. S., Gait, M. J., & Lindsay, M. A. (2007) · Bioconjugate Chemistry · doi:10.1021/bc070077d · Cited by 356
The Dual Role of TGFβ in Human Cancer: From Tumor Suppression to Cancer Metastasis
Neel, J.-C., Humbert, L., & Lebrun, J. J. (2012) · ISRN Molecular Biology · doi:10.5402/2012/381428 · Cited by 367
MicroRNA control of muscle development and disease
Williams, A. H., Liu, N., van Rooij, E., & Olson, E. N. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.01.029 · Cited by 347
TGFβ-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3
Wang, B., Hsu, S., Majumder, S., Kutay, H., Huang, W., Jacob, S. T., & Ghoshal, K. (2009) · Oncogene · doi:10.1038/onc.2009.468 · Cited by 350
Corsten, M. F., Miranda, R., Kasmieh, R., Krichevsky, A. M., Weissleder, R., & Shah, K. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1045 · Cited by 406
Crist, C. G., Montarras, D., & Buckingham, M. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.03.011 · Cited by 346
miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer
Giannakakis, A., Sandaltzopoulos, R., Greshock, J. D., Liang, S., Huang, J., Hasegawa, K., Li, C., O’Brien-Jenkins, A., Katsaros, D., Weber, B. L., et al. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.2.5297 · Cited by 348
The role of microRNAs in cancer: No small matter
Wiemer, E. A. C. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.04.002 · Cited by 348
MicroRNA-Mediated Control of Cell Fate in Megakaryocyte-Erythrocyte Progenitors
Lu, J., Guo, S., Ebert, B. L., Zhang, H., Peng, X., Bosco, J., Pretz, J., Schlanger, R., Wang, J. Y., Mak, R. H., et al. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.03.012 · Cited by 310
van Rooij, E., Liu, N., & Olson, E. N. (2008) · Trends in Genetics · doi:10.1016/j.tig.2008.01.007 · Cited by 347
RNA-ligase-dependent biases in miRNA representation in deep-sequenced small RNA cDNA libraries
Hafner, M., Renwick, N., Brown, M., Mihailović, A., Holoch, D., Lin, C., Pena, J. T. G., Nusbaum, J. D., Morozov, P., Ludwig, J., et al. (2011) · RNA · doi:10.1261/rna.2799511 · Cited by 320
Self-citationMicroRNA-125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer’s disease
Banzhaf‐Strathmann, J., Benito, E., May, S., Arzberger, T., Tahirovic, S., Kretzschmar, H., Fischer, A., & Edbauer, D. (2014) · The EMBO Journal · doi:10.15252/embj.201387576 · Cited by 347
Causes and Consequences of MicroRNA Dysregulation
Iorio, M. V., & Croce, C. M. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e318250c001 · Cited by 337
Developing therapeutic microRNAs for cancer
Bader, A. G., Brown, D., Stoudemire, J., & Lammers, P. (2011) · Gene Therapy · doi:10.1038/gt.2011.79 · Cited by 346
Adult-specific functions of animal microRNAs
Sun, K., & Lai, E. C. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3471 · Cited by 335
RNA-based diagnostic and therapeutic strategies for cardiovascular disease
Lu, D., & Thum, T. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0218-x · Cited by 341
MicroRNA miR-125a controls hematopoietic stem cell number
Guo, S., Lu, J., Schlanger, R., Zhang, H., Wang, J. Y., Fox, M. C., Purton, L. E., Fleming, H. H., Cobb, B., Merkenschlager, M., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913574107 · Cited by 310
MicroRNA-374a activates Wnt/β-catenin signaling to promote breast cancer metastasis
Cai, J., Guan, H., Fang, L., Yang, Y., Zhu, X., Yuan, J., Wu, J., & Li, M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65871 · Cited by 339
Cheng, Y., Zhu, P., Yang, J., Liu, X., Dong, S., Wang, X., Chun, B., Zhuang, J., & Zhang, C. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq082 · Cited by 331
Sequence-based design of bioactive small molecules that target precursor microRNAs
Velagapudi, S. P., Gallo, S. M., & Disney, M. D. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1452 · Cited by 330
Therapeutic potential of microRNA in tendon injuries
Giordano, L., Porta, G. D., Peretti, G. M., & Maffulli, N. (2020) · British Medical Bulletin · doi:10.1093/bmb/ldaa002 · Cited by 330
MicroRNAs and cardiac pathology
Latronico, M. V. G., & Condorelli, G. (2009) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.56 · Cited by 320
Inference of miRNA targets using evolutionary conservation and pathway analysis
Gaidatzis, D., van Nimwegen, E., Hausser, J., & Zavolan, M. (2007) · BMC Bioinformatics · doi:10.1186/1471-2105-8-69 · Cited by 335
Martins, P. A. D. C., Salic, K., Gladka, M. M., Armand, A., Leptidis, S., el Azzouzi, H., Hansen, A., Roo, C. J. J. C., Bierhuizen, M. F. A., van der Nagel, R., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2126 · Cited by 331
Lost in translation: an assessment and perspective for computational microRNA target identification
Alexiou, P., Maragkakis, M., Papadopoulos, G. L., Reczko, M., & Hatzigeorgiou, A. G. (2009) · Computer applications in the biosciences · doi:10.1093/bioinformatics/btp565 · Cited by 330
Diabetic nephropathy—emerging epigenetic mechanisms
Kato, M. V., & Natarajan, R. D. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.116 · Cited by 319
Mikhaylova, O., Stratton, Y., Hall, D., Kellner, E., Ehmer, B., Drew, A. F., Gallo, C. A., Plas, D. R., Biesiada, J., Meller, J., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.019 · Cited by 283
The art of CHO cell engineering: A comprehensive retrospect and future perspectives
Fischer, S., Handrick, R., & Otte, K. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.10.015 · Cited by 336
Dysregulation of microRNAs in cancer: Playing with fire
Melo, S. A., & Esteller, M. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.08.009 · Cited by 324
Stittrich, A., Haftmann, C., Sgouroudis, E., Kühl, A. A., Hegazy, A. N., Panse, I., Riedel, R., Floßdorf, M., Dong, J., Fuhrmann, F., et al. (2010) · Nature Immunology · doi:10.1038/ni.1945 · Cited by 318
Self-citationGaidatzis, D., Burger, L., Florescu, M., & Stadler, M. B. (2015) · Nature Biotechnology · doi:10.1038/nbt.3269 · Cited by 313
MicroRNAs in idiopathic pulmonary fibrosis
Pandit, K. V., Milošević, J., & Kaminski, N. (2011) · Translational research · doi:10.1016/j.trsl.2011.01.012 · Cited by 318
The role of microRNAs in endometriosis and associated reproductive conditions
Ohlsson Teague, E. M. C., Print, C. G., & Hull, M. L. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmp034 · Cited by 309
The role of microRNAs in colorectal cancer
Schetter, A. J., Okayama, H., & Harris, C. C. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e318258b78f · Cited by 252
Altered MicroRNA Expression in Cervical Carcinomas
Lee, J., Choi, C. H., Choi, J., Park, Y.-A., Kim, S.-J., Hwang, S. Y., Kim, W. Y., Kim, T., Lee, J., Kim, B., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1231 · Cited by 313
MicroRNA-221 Targets Bmf in Hepatocellular Carcinoma and Correlates with Tumor Multifocality
Gramantieri, L., Fornari, F., Ferracin, M., Veronese, A., Sabbioni, S., Calin, G. A., Grazi, G. L., Croce, C. M., Bolondi, L., & Negrini, M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0092 · Cited by 308
Transfection types, methods and strategies: a technical review
Chong, Z. X., Yeap, S. K., & Ho, W. Y. (2021) · PeerJ · doi:10.7717/peerj.11165 · Cited by 342
Li, J. J., Bickel, P. J., & Biggin, M. D. (2014) · PeerJ · doi:10.7717/peerj.270 · Cited by 279
Liposome-based drug co-delivery systems in cancer cells
Vahed, S. Z., Salehi, R., Davaran, S., & Sharifi, S. (2016) · Materials Science and Engineering C · doi:10.1016/j.msec.2016.11.073 · Cited by 317
Regulation of Hepatitis C Virus Translation and Infectious Virus Production by the MicroRNA miR-122
Jangra, R. K., Yi, M., & Lemon, S. M. (2010) · Journal of Virology · doi:10.1128/jvi.00417-10 · Cited by 306
Recent insights on the role of cholesterol in non-alcoholic fatty liver disease
Argüello, G., Balboa, E., Arrese, M. A., & Zanlungo, S. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.05.015 · Cited by 320
Haraguchi, T., Ozaki, Y., & Iba, H. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp040 · Cited by 305
Chen, P.-Y., Qin, L., Barnes, C., Charisse, K., Yi, T., Zhang, X., Ali, R., Medina, P. P., Yu, J., Slack, F. J., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.10.021 · Cited by 304
Discovering the first microRNA-targeted drug
Lindow, M., & Kauppinen, S. (2012) · The Journal of Cell Biology · doi:10.1083/jcb.201208082 · Cited by 315
Wang, B., Majumder, S., Nuovo, G. J., Kutay, H., Volinia, S., Patel, T. C., Schmittgen, T. D., Croce, C. M., Ghoshal, K., & Jacob, S. T. (2009) · Hepatology · doi:10.1002/hep.23100 · Cited by 305
Yin, H., Pasut, A., Soleimani, V. D., Bentzinger, C. F., Antoun, G., Thorn, S., Seale, P., Fernando, P., van IJcken, W., Grosveld, F., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.01.004 · Cited by 293
MicroRNA involvement in hepatocellular carcinoma
Gramantieri, L., Fornari, F., Callegari, E., Sabbioni, S., Lanza, G., Croce, C. M., Bolondi, L., & Negrini, M. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00533.x · Cited by 305
MicroRNAs in Heart Failure: From Biomarker to Target for Therapy
Vegter, E. L., van der Meer, P., Windt, L. J. D., Pinto, Y. M., & Voors, A. A. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.495 · Cited by 313
MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment
Quiat, D., & Olson, E. N. (2013) · Journal of Clinical Investigation · doi:10.1172/jci62876 · Cited by 307
Diabetes mellitus, a microRNA-related disease?
Guay, C., Roggli, E., Nesca, V., Jacovetti, C., & Regazzi, R. (2011) · Translational research · doi:10.1016/j.trsl.2011.01.009 · Cited by 305
lnc RNA H19/miR‐675 axis represses prostate cancer metastasis by targeting TGFBI
Zhu, M., Chen, Q., Liu, X., Sun, Q., Zhao, X., Deng, R., Wang, Y., Huang, J. J., Xu, M., Yan, J., et al. (2014) · FEBS Journal · doi:10.1111/febs.12902 · Cited by 299
Baumann, V., & Winkler, J. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.14.116 · Cited by 309
Zhang, Y., Li, M., Wang, H., Fisher, W. E., Lin, P. H., Yao, Q. C., & Chen, C. (2008) · World Journal of Surgery · doi:10.1007/s00268-008-9833-0 · Cited by 303
miR‐155: an ancient regulator of the immune system
Vigorito, E., Kohlhaas, S. L., Lu, D., & Leyland, R. (2013) · Immunological Reviews · doi:10.1111/imr.12057 · Cited by 296
RNAi-based drug design: considerations and future directions
Tang, Q., & Khvorova, A. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-00912-9 · Cited by 330
Ji, J., Zhang, J., Huang, G., Qian, J., Wang, X., & Mei, S. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.01.034 · Cited by 295
A Limited Set of Human MicroRNA Is Deregulated in Follicular Thyroid Carcinoma
Weber, F., Teresi, R. E., Broelsch, C. E., Frilling, A., & Eng, C. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0693 · Cited by 296
Qi, P., Cheng, S., Wang, H., Li, N., Chen, Y., & Gao, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028486 · Cited by 288
New methods in the diagnosis of cancer and gene therapy of cancer based on nanoparticles
Zaimy, M. A., Saffarzadeh, N., Mohammadi, A., Pourghadamyari, H., Izadi, P., Sarli, A., Moghaddam, L. K., Paschepari, S. R., Azizi, H., Torkamandi, S., et al. (2017) · Cancer Gene Therapy · doi:10.1038/cgt.2017.16 · Cited by 294
Diabetes Complications: The MicroRNA Perspective
Kantharidis, P., Wang, B., Carew, R. M., & Lan, H. Y. (2011) · Diabetes · doi:10.2337/db11-0082 · Cited by 292
Delivering the promise of miRNA cancer therapeutics
Pereira, D. M., Rodrigues, P. M., Borralho, P. M., & Rodrigues, C. M. P. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.10.002 · Cited by 293
Park, J. K., Lee, E. J., Esau, C., & Schmittgen, T. D. (2009) · Pancreas · doi:10.1097/mpa.0b013e3181ba82e1 · Cited by 293
microRNAs in the Regulation of Adipogenesis and Obesity
McGregor, R. A., & Choi, M. (2011) · Current Molecular Medicine · doi:10.2174/156652411795677990 · Cited by 287
RNAi‐based therapeutics–current status, challenges and prospects
Tiemann, K., & Rossi, J. J. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900023 · Cited by 285
Moschos, S. A., Williams, A. E., Perry, M. M., Birrell, M. A., Belvisi, M. G., & Lindsay, M. A. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-240 · Cited by 286
Emerging Role of MicroRNAs in Cardiovascular Biology
Latronico, M. V. G., Catalucci, D., & Condorelli, G. (2007) · Circulation Research · doi:10.1161/circresaha.107.163147 · Cited by 285
The powerful world of antisense oligonucleotides: From bench to bedside
Quéméner, A. M., Bachelot, L., Forestier, A., Donnou‐Fournet, E., Gilot, D., & Galibert, M. (2020) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1594 · Cited by 284
Thioredoxin-interacting protein regulates insulin transcription through microRNA-204
Xu, G., Chen, J., Gu, J., & Shalev, A. (2013) · Nature Medicine · doi:10.1038/nm.3287 · Cited by 282
Wang, X. W., Heegaard, N. H. H., & Ørum, H. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.007 · Cited by 289
Scioli, M. G., Storti, G., D’Amico, F., Rodríguez Guzmán, R., Centofanti, F., Doldo, E., Céspedes Miranda, E. M., & Orlandi, A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061995 · Cited by 281
The microRNA-200 family regulates pancreatic beta cell survival in type 2 diabetes
Belgardt, B., Ahmed, K., Spranger, M., Latreille, M., Denzler, R., Kondratiuk, N., von Meyenn, F., Villena, F. N., Herrmanns, K., Bosco, D., et al. (2015) · Nature Medicine · doi:10.1038/nm.3862 · Cited by 283
Self-citationThe emerging roles of microRNAs in CNS injuries
Bhalala, O. G., Srikanth, M., & Kessler, J. A. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.67 · Cited by 248
Exosomes as nucleic acid nanocarriers
van den Boorn, J. G., Daßler, J., Coch, C., Schlee, M., & Hartmann, G. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.06.011 · Cited by 285
MicroRNA dysregulation in gastric cancer: a new player enters the game
Wu, W. K. K., Lee, C., Cho, C. H., Fan, D., Wu, K., Yu, J. Q., & Sung, J. J. �. (2010) · Oncogene · doi:10.1038/onc.2010.352 · Cited by 279
Anti-miRNA oligonucleotides: A comprehensive guide for design
Lima, J., Cerqueira, L., Figueiredo, C., Oliveíra, C., & Azevedo, N. F. (2018) · RNA Biology · doi:10.1080/15476286.2018.1445959 · Cited by 286
MicroRNA-184 antagonizes microRNA-205 to maintain SHIP2 levels in epithelia
Yu, J., Ryan, D. G., Getsios, S., Oliveira-Fernandes, M., Fatima, A., & Lavker, R. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803992105 · Cited by 283
Intronic miR-211 Assumes the Tumor Suppressive Function of Its Host Gene in Melanoma
Levy, C., Khaled, M., Iliopoulos, D., Janas, M. M., Schubert, S., Pinner, S. E., Chen, P., Li, S., Fletcher, A. L., Yokoyama, S., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.11.020 · Cited by 284
MicroRNAs as novel biological targets for detection and regulation
Li, J., Tan, S., Kooger, R., Zhang, C., & Zhang, Y. (2013) · Chemical Society Reviews · doi:10.1039/c3cs60312a · Cited by 275
MicroRNAs shape the neuronal landscape
McNeill, E., & Van Vactor, D. (2012) · Neuron · doi:10.1016/j.neuron.2012.07.005 · Cited by 274
van der Ree, M. H., de Vree, J. M., Stelma, F., Willemse, S. B., van der Valk, M., Rietdijk, S. T., Molenkamp, R., Schinkel, J., van Nuenen, A. C., Beuers, U. H., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31715-9 · Cited by 271
Wu, R., Zeng, J., Yuan, J., Deng, X.-J., Huang, Y., Chen, L., Zhang, P., Feng, H., Liu, Z., Wang, Z., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97426 · Cited by 276
The prognostic and functional role of microRNAs in acute myeloid leukemia
Marcucci, G., Mrózek, K., Radmacher, M. D., Garzon, R., & Bloomfield, C. D. (2010) · Blood · doi:10.1182/blood-2010-09-191312 · Cited by 274
Epigenetic Activation of Tumor Suppressor MicroRNAs in Human Cancer Cells
Saito, Y., & Jones, P. M. (2006) · Cell Cycle · doi:10.4161/cc.5.19.3340 · Cited by 274
Solingen, C. V., Seghers, L., Bijkerk, R., Duijs, J. M. G. J., Roeten, M. K., van Oeveren‐Rietdijk, A. M., Baelde, H. J., Monge, M., Vos, J. B., de Boer, H. C., et al. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00613.x · Cited by 267
Xu, H. M., He, J., Xiao, Z., Zhang, Q.-Q., Chen, Y.-Q., Zhou, H., & Qu, L. (2010) · Hepatology · doi:10.1002/hep.23818 · Cited by 273
MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma
Hiyoshi, Y., Kamohara, H., Karashima, R., Sato, N., Imamura, Y., Nagai, Y., Yoshida, N., Toyama, E., Hayashi, N., Watanabe, M., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2545 · Cited by 269
An Integrated Approach for Experimental Target Identification of Hypoxia-induced miR-210
Fasanaro, P., Greco, S., Lorenzi, M., Pescatori, M., Brioschi, M., Kulshreshtha, R., Banfi, C., Stubbs, A., Calin, G. A., Ivan, M., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.052779 · Cited by 275
Ellison, G. M., Waring, C. D., Vicinanza, C., & Torella, D. (2011) · Heart · doi:10.1136/heartjnl-2011-300639 · Cited by 280
Cell-free 3D scaffold with two-stage delivery of miRNA-26a to regenerate critical-sized bone defects
Zhang, X., Li, Y., Chen, Y. E., Chen, J., & Ma, P. X. (2016) · Nature Communications · doi:10.1038/ncomms10376 · Cited by 270
Oligonucleotide Therapies: The Past and the Present
Lundin, K. E., Gissberg, O., & Smith, C. I. E. (2015) · Human Gene Therapy · doi:10.1089/hum.2015.070 · Cited by 271
Long, J., Wang, Y., Wang, W., Chang, B. H., & Danesh, F. R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.194969 · Cited by 269
MYCN regulates oncogenic MicroRNAs in neuroblastoma
Schulte, J. H., Horn, S., Otto, T., Samans, B., Heukamp, L. C., Eilers, U., Krause, M., Astrahantseff, K., Klein‐Hitpaß, L., Buettner, R., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.23153 · Cited by 267
Mammalian cell penetration, siRNA transfection, and DNA transfection by supercharged proteins
McNaughton, B. R., Cronican, J. J., Thompson, D. B., & Liu, D. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807883106 · Cited by 274
The Emerging Role of MicroRNAs in Cardiac Remodeling and Heart Failure
Divakaran, V. G., & Mann, D. L. (2008) · Circulation Research · doi:10.1161/circresaha.108.183087 · Cited by 267
Metadata
- Authors
- Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M.
- Affiliations
- Rockefeller University (US)
- New York University (US)
- Alnylam Pharmaceuticals (United States) (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Stoffel, Markus
- ORCID
- Venue
- Nature
- Published
- 2005-10-30
- Volume
- 438
- Issue
- 7068
- Pages
- 685-689
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2161693225
- Cited by
- 3,949
- References
- 27
- Citations by year
- 2026: 51 · 2025: 75 · 2024: 98 · 2023: 109 · 2022: 138 · 2021: 148 · 2020: 155 · 2019: 135 · 2018: 169 · 2017: 169 · 2016: 210 · 2015: 249 · 2014: 326 · 2013: 329 · 2012: 318
- FWCI
- 52.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Bern Open Repository and Information System (University of Bern) (submittedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- Funders
- Bristol-Myers Squibb
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Plant Molecular Biology Research
- Keywords
- microRNA, antagomir, microRNA silencing, in vivo gene regulation, miR-122, miR-16, miR-192, miR-194, miR-196, Hoxb8, Sonic hedgehog, embryonic development, non-coding RNA, oligonucleotide therapeutics
- MeSH terms
- Antagomirs, Animals, Cholesterol, Oligonucleotides, Sensitivity and Specificity, Substrate Specificity, Time Factors, Down-Regulation, Up-Regulation, RNA, Complementary, Computational Biology, 3' Untranslated Regions, Gene Silencing, MicroRNAs, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review